EDGAR Filing Documents for 0001279569-13-000499

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-13-000499

Filing Date

2013-04-17

Accepted

2013-04-17 11:41:40

Documents

Period of Report

2013-04-15

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v341438_6k.htm	6-K	12075
2	EXHIBIT 99.1	v341438_ex991.htm	EX-99.1	84308
3	EXHIBIT 99.2	v341438_ex992.htm	EX-99.2	247533
4	EXHIBIT 99.3	v341438_ex993.htm	EX-99.3	171635
5	EXHIBIT 99.4	v341438_ex994.htm	EX-99.4	21157
6	GRAPHIC	tlogo.jpg	GRAPHIC	11718
	Complete submission text file	0001279569-13-000499.txt		554206

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 13766203
SIC: 2836 Biological Products, (No Diagnostic Substances)